1-2 of 2
Sandra Kluth, Dr.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Subclonal Driver Mutations Predict Shorter Progression Free Survival in Chronic Lymphocytic Leukemia Following First-Line Chemo(immuno)Therapy: Results from the CLL8 Trial

Dan A. Landau, MD PhD, Eugen Tausch, MD, Amaro N Taylor-Weiner, BS, Sebastian Bottcher, MD, Jasmin Bahlo, Chip Stewart, PhD, Jennifer Edelmann, MD, Sandra Kluth, Dr., Daniel Mertens, PhD, Michael Kneba, MD PhD, Sabrina Kless, Carrie Sougnez, Kirsten Fischer, MD, Matthias Ritgen, Stacey Gabriel, PhD, Eric Lander, PhD, Hartmut Dohner, MD, Michael Hallek, MD, Gad Getz, PhD, Donna Neuberg, ScD, Stephan Stilgenbauer, MD, Catherine J. Wu, MD
Journal: Blood
Blood (2014) 124 (21): 1938.
https://doi.org/10.1182/blood.V124.21.1938.1938
Published: 2014
Journal Articles

Value of Minimal Residual Disease (MRD) Negative Status at Response Evaluation in Chronic Lymphocytic Leukemia (CLL): Combined Analysis of Two Phase III Studies of the German CLL Study Group (GCLLSG)

Gabor Kovacs, MD, Sebastian Boettcher, MD, Jasmin Bahlo, Sandra Kluth, Dr., Matthias Ritgen, Anna Maria Fink, MD, Irene Stodden, Paula Cramer, MD, Julia von Tresckow, MD, Christian Maurer, MD, Hartmut Doehner, Prof., Stephan Stilgenbauer, MD, Michael Kneba, MD PhD, Kirsten Fischer, Michael Hallek, MD, Barbara Eichhorst, MD
Journal: Blood
Blood (2014) 124 (21): 23.
https://doi.org/10.1182/blood.V124.21.23.23
Published: 2014